Nuwae believes there should be one price for a drug: the lowest price. We are industry veterans—specialists with deep experience and unique relationships which give us unique insight into the way these systems work and where they can be reformed in favor of better outcomes that benefit more people. #employeebenefits #pharmacybenefits
Nuwae 的动态
最相关的动态
-
Read the latest Drug Diversion Case Study by #KLASResearch for DetectRx. Explore the solution #RenownHealth and #PetersonHealth are using to monitor and prevent drug diversion. Preview: “In using the product, I found a few instances of diversion immediately, so the product kind of sold itself to me. I had been monitoring diversion manually and through another system, and I am not sure that I would have caught them." - Director ??: https://bit.ly/4fVyZZo iatric.com
-
-
?? Missed the March video review? We talked about the progress of our hospitals' deployments, the repurposing of drugs, and more hot topics! It's ok, you can still catch up Galeon's latest news here, tune in! ?? https://lnkd.in/ecNb6MPM
Galeon March 2024 news: repurposing of drugs, Santexpo and more
https://www.youtube.com/
-
Are you in need of a drug test? Here's 4 reasons why EZ Labs should be your first choice! #rockhillsc #fortmillsc #charlottenc #yorkcountysc #drugtestingsaveslives #drugtestingservices
-
-
Curious about drug tests? Fastest Labs guides you through drug test options. Your journey starts here, and we're here to make it seamless, informative, and uniquely yours. ???? #FastestLabsHTXSC #SmallBusiness #CleanFastFriendly
-
-
In Fear & Greed's summer series, Steve Wheen chatted to Sean Aylmer about some of the biggest developments in the healthcare sector, including the arrival of GLP-1 drugs like Ozempic and Wegovy. ?? https://lnkd.in/gvHXwGk3
-
-
?? The final report in our 2024 series uncovers important #workcomp high-impact drug class patterns. Read part 4 of our drug trends analysis to learn more about these cost drivers: https://bit.ly/3AOgTIZ
-
Transparent Rx Evangelist | Healthcare Innovator, Relationship Curator, Pharmacy Benefits SME
Have you ever played monopoly with someone who had loaded their property with hotels? It's game over if you land there. The US Pharma patent game is a lot like monopoly. Except in this game, patients are stuck with no option but to pay the cost of the "property". This is how drugs like Humira made $47.5 million per day before a competitor enters the market. What do you think? Are drug patents protecting innovation or penalizing the sick? Please add your insight in the comments.
-
-
The final report in our 2024 series uncovers important #workcomp high impact drug class patterns. Read part 4 of our drug trends analysis to learn more about these cost drivers. https://lnkd.in/ebUb-2dT
-
Read to understand more about the drug therapies that COUR is working on!
In this Drug Target Review article, our CEO, John J. Puisis, discusses our versatile #nanoparticle platform and its potential to treat #AutoimmuneDiseases like #MyastheniaGravis and #Type1Diabetes. Read more here: https://bit.ly/3ySKjok
-
-
????Take another look at our #HighlyCitedPaper by Aida López Ruiz et al: Single and Multiple Stimuli-Responsive Polymer Particles for Controlled Drug Delivery" You can find it at: https://shorturl.at/eopL8
-
